Disease | renal cell carcinoma |
Phenotype | C0278883|metastatic melanoma |
Sentences | 1 |
PubMedID- 25892889 | Although ipilimumab has been shown to improve survival in patients with metastatic melanoma and cause regression of metastatic renal cell carcinoma, the associated immune-related toxicities are of concern. |
Page: 1